[1]曾微微,麦联任,张 玲,等.健胃益脾汤治疗慢性萎缩性胃炎疗效及对患者胃蛋白酶原的影响*[J].陕西中医,2020,(11):1548-1551.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.008]
　ZENG Weiwei,MAI Lianren,ZHANG Ling,et al.Effect of Jianwei Yipi decoction on treating chronic atrophic gastritis and its influence on pepsinogen[J].,2020,(11):1548-1551.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.008]
点击复制

健胃益脾汤治疗慢性萎缩性胃炎疗效及对患者胃蛋白酶原的影响*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年11期
页码:
1548-1551
栏目:
临床研究
出版日期:
2020-11-05

文章信息/Info

Title:
Effect of Jianwei Yipi decoction on treating chronic atrophic gastritis and its influence on pepsinogen
作者:
曾微微1; 麦联任1; 张 玲1; 吴红艳2
1.海南省中医院脾胃肝病科(海口570203); 2.河南省职工医院消化内科(郑州 450002)
Author(s):
ZENG Weiwei; MAI Lianren; ZHANG Ling; et al.
Department of Spleen and Stomach Hepatology,Hainan Hospital of Traditional Chinese Medicine(Haikou 570203)
关键词:
慢性萎缩性胃炎;  肠上皮化生;  异型增生;  胃炎分期标准;  肠化生分期标准;  胃蛋白酶原
Keywords:
Chronic atrophic gastritis;  Intestinal metaplasia;  Dysplasia;  Gastritis staging criteria;  Intestinal metaplasia stage standard;  Pepsinogen
分类号:
R573.32
DOI:
DOI:10.3969/j.issn.1000-7369.2020.11.008
文献标志码:
A
摘要:
目的:研究健胃益脾汤治疗慢性萎缩性胃炎(CAG)的疗效及对患者胃蛋白酶原等的影响。方法:选取96例CAG患者纳入本次研究。入选患者按随机数字表法均分后分别纳入常规组与观察组,常规组给予摩罗丹治疗,观察组给予健胃益脾汤治疗; 治疗3个月后,观察两组患者胃镜下病理积分、胃炎分期评分、肠化生分期评分、中医证候积分、实验室指标的变化情况。结果:治疗前两组患者各项中医证候积分、病理萎缩与IM积分、OLGA、OLGIM评分比较,差异无统计学意义(P>0.05); 治疗后,两组患者中医主症:胃痛、胃脘痞闷与次症纳差、反酸、大便异常、倦怠乏力积分,胃窦大小弯、胃体大小弯、胃角病理萎缩与IM积分,OLGA、OLGIM评分均较治疗前降低(P<0.05),观察组均低于常规组(P<0.05)。结论:健胃益脾汤治疗慢性萎缩性胃炎疗效确切,能够改善患者病理评分,缓解患者临床症状。
Abstract:
Objective:To observe the clinical efficacy of Jianwei Yipi decoction in the treatment of Chronic atrophic gastritis(CAG)and its effect on the pathological score of patients.Methods:96 patients with CAG were included in this study.The patients were divided into the conventional group and the observation group according to the random number method.The conventional group was treated with Moluo tablet,and the observation group was treated with Jianwei Yipi decoction.After 3 months of treatment,the changes of pathology score,gastritis staging score,intestinal metaplasia score and TCM syndrome score were observed in the two groups.Results:No statistical differences were found in TCM syndrome scores,pathological atrophy,IM scores,OLGA and OLGIM scores between the two groups before treatment(P>0.05).After treatment,the main TCM symptoms of the patients in the two groups were stomachache,epigastric pain,poor appetite for secondary diseases,acid reflux,abnormal stools,fatigue and fatigue scores,large and small gastric antrum curvature,large and small gastric body curvature,pathological atrophy of gastric angle,and IM scores.OLGA and OLGIM scores were all lower than those before treatment(P<0.05),and the observation group was lower than the conventional group(P<0.05).Conclusion:Jianwei Yipi decoction has an accurate and ideal therapeutic effect on chronic atrophic gastritis,which can more effectively improve the pathological score of patients and alleviate the main symptoms and secondary syndromes of patients.

参考文献/References:

[1] 张剑治,冯全林,胡漪璐,等.慢性萎缩性胃炎中医证型与Hp、IL-1β及其基因多态性的相关性[J].中国中西医结合杂志,2015,35(12):1433-1436.
[2] 侯建明,杨改姣,宋永玲.胃康宁颗粒与胃复春片治疗慢性萎缩性胃炎癌前病变的临床对照研究[J].药物评价研究,2017,40(8):1138-1140.
[3] 张越亚,杨国红.慢性萎缩性胃炎癌前病变中医药研究进展[J].中医临床研究,2017,9(2):146-148.
[4] 徐纪文.黄芪建中汤辨证加减治疗慢性浅表性胃炎迁延所致慢性萎缩性胃炎的疗效观察[J].陕西中医,2016,37(2):142-144.
[5] Chen HN,Wang Z,Li X,et al.Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia:evidence from a meta[J].Gastric Cancer,2016,19(1):166-175.
[6] Zhou Y,Li HY,Zhang JJ,et al.Operative link on gastritis assessment stage is an appropriate predictor of early gastric cancer[J].World J Gastroenterol,2016,22(13):3670-3678.
[7] 中华医学会消化病学分会.中国慢性胃炎共识意见[J].胃肠病学,2013,18(1):24-36.
[8] 中华中医药学会脾胃病分会.慢性萎缩性胃炎中医诊疗共识意见[J].中国中西医结合消化杂志,2010,18(5):345-349.
[9] 张玉峰,刘新爱,叶坤英,等.参枳消萎汤对慢性萎缩性胃炎癌前病(肝胃气滞证)变转归的影响[J].中国实验方剂杂志,2016,22(4):174-177.
[10] Capelle LG,De VA,Haringsma J,et al.The staging of gastritis with the OLGA system by using intestinal metaplasia as an accuratealte rnative for atrophic gastritis[J].Gastrointestinal Endoscopy,2010,71(7):1150-1158.
[11] 兰 青,马尚清,赵 兵,等.健脾通络汤治疗慢性萎缩性胃炎伴广泛肠化脾胃虚弱证的疗效观察[J].中华中医药杂志,2019,34(8):3880-3882.
[12] 李诗国,李武峰.山腊梅叶煎剂治疗慢性萎缩性胃炎癌前病变48例临床观察[J].浙江中医杂志,2017,52(6):415.
[13] 刘冬梅,房 墅,张 新,等.中医解毒法治疗慢性萎缩性胃炎癌前病变的实验研究进展[J].上海中医药杂志,2016,50(9):101-103.
[14] 牛晓玲,孙志广,费建飚,等.从寒湿毒论治慢性萎缩性胃炎癌前病变的临床观察[J].辽宁中医杂志,2017,44(3):528-530.
[15] 梁慕华,郭莉阁.益气活血养阴法对慢性萎缩性胃炎治疗效果及血液流变学的影响[J].中华中医药学刊,2016,34(7):1704-1707.
[16] 张 驰,甄海洋.胃黏膜病变与幽门螺杆菌感染的临床分析[J].陕西医学杂志,2016,45(9):1193-1194.
[17] 吴红苗,缪 新,杨军强,等.养胃消瘀汤对慢性萎缩性胃炎癌前病变患者环氧酶的影响[J].深圳中西医结合杂志,2017,27(7):48-49.
[18] 崔娜妮.胃广平颗粒治疗脾虚气滞型慢性萎缩性胃炎癌前病变的临床疗效分析[J].内蒙古中医药,2017,36(7):43-44.

相似文献/References:

[1]孙明明,李 聪,史 林.王庆国教授对慢性萎缩性胃炎的治疗经验探析[J].陕西中医,2019,(2):260.
　SUN Mingming,LI Cong,SHI Lin..Analysis on the treatment experience of chronic atrophic gastritis by professor WANG Qingguo[J].,2019,(11):260.
[2]钱元霞,汤玲珺,钱 祯,等.四逆散对慢性萎缩性胃炎癌前病变大鼠的作用及机制研究*[J].陕西中医,2019,(8):990.
　QIAN Yuanxia,TANG Lingjun,QIAN Zhen,et al.The effect of Sinisan on the rats of precancerous lesion of chronic atrophic gastritis and its mechanism[J].,2019,(11):990.
[3]闫 强,杨国强 △.健脾清胃汤治疗脾胃虚弱型慢性萎缩性胃炎疗效及对患者免疫功能的影响[J].陕西中医,2019,(8):1014.
　YAN Qiang,YANG Guoqiang..Effect of Jianpi Qingwei decoction on chronic atrophic gastritis of spleen and stomach deficiency and its influence on patients' immune function[J].,2019,(11):1014.
[4]杨宏升.安胃活血汤联合序贯法治疗慢性萎缩性胃炎胃癌前病变疗效研究[J].陕西中医,2019,(9):1195.
　YANG Hongsheng..Effect of Anwei Huoxue decoction combined with sequential therapy on gastric precancerous lesions of chronic atrophic gastritis[J].,2019,(11):1195.
[5]马佳乐 ,李慧臻.中医治疗慢性萎缩性胃炎研究进展*[J].陕西中医,2019,(11):1646.
　MA Jiale,LI Huizhen..Traditional Chinese medicine in the treatment of chronic atrophic gastritis[J].,2019,(11):1646.
[6]王 阳.基于络病理论探析慢性萎缩性胃炎“气络失和,毒损血络”病机*[J].陕西中医,2020,(11):1632.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.030]
　WANG Yang..Analysis of pathogenesis of chronic atrophic gastritis based on collateral disease theory[J].,2020,(11):1632.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.030]
[7]蔺焕萍,王 峰,周晓燕,等.李守朝教授治疗胃癌前病变临证经验拾萃[J].陕西中医,2021,(1):103.[doi:DOI:10.3969/j.issn.1000-7369.2020.01.028]
　LIN Huanping,WANG Feng,ZHOU Xiaoyan,et al.Professor LI Shouchao's experience in the treatment of precancerous lesions of gastric cancer[J].,2021,(11):103.[doi:DOI:10.3969/j.issn.1000-7369.2020.01.028]
[8]张紫涵,陈 俊,徐 丹.苦参碱联合胃复春片治疗慢性萎缩性胃炎疗效及对患者血清胃蛋白酶原亚群的影响[J].陕西中医,2021,(3):323.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.013]
　ZHANG Zihan,CHEN Jun,XU Dan.Effect of matrine combined with Weifuchun tablet on efficacy and serum pepsinogen subgroup in patients with chronic atrophic gastritis[J].,2021,(11):323.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.013]
[9]张 鹏,于 勇,万 强,等.补虚养胃汤加减治疗慢性萎缩性胃炎疗效及对患者胃肠功能的影响[J].陕西中医,2022,(1):66.[doi:DOI:10.3969/j.issn.1000-7369.2022.01.016]
[10]王雨鸽,许静茹,王俞铧,等.刘启泉教授基于“随变而调气”论治慢性萎缩性胃炎[J].陕西中医,2022,(2):236.[doi:DOI:10.3969/j.issn.1000-7369.2022.02.023]
　WANG Yuge,XU Jingru,WANG Yuhua,et al.Treatment of chronic atrophic gastritis based on “regulating qi with changes” by professor LIU Qiquan[J].,2022,(11):236.[doi:DOI:10.3969/j.issn.1000-7369.2022.02.023]
[11]寇 媛,闻新丽,薛 峰.养胃清热化瘀汤治疗慢性萎缩性胃炎及癌前病变临床研究[J].陕西中医,2021,(9):1233.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.021]
　KOU Yuan,WEN Xinli,XUE Feng.Clinical study on Yangwei Qingre Huayu decoction in treatment of chronic atrophic gastritis and precancerous lesions[J].,2021,(11):1233.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.021]

备注/Memo

备注/Memo:
*河南省医学科技攻关项目(201602203)
更新日期/Last Update: 2020-11-09